Ocuigen is unlikely to be able to get Covaxin widely distributed in the U.S. until Spring 2023. By that time, the shot won't help OCGN stock much if at all.
Shares of biopharmaceutical company Ocugen Inc. (NASDAQ: OCGN) fell 2% in Tuesday's regular trading session after seeing strong gains on Monday. What Happened: Ocugen's stock fell more than 2% to $9.1
Ocugen Inc. (NASDAQ: OCGN) shares are trading higher Tuesday ahead of a key World Health Organization meeting. The WHO meeting will decide whether or not to grant emergency use approval for the COVI
OCGN stock is racing higher as the WHO kicks off its review of partner Bharat Biotech's COVAXIN vaccine. Here's what to know.

OCGN Stock: Why The Price Increased Today

07:37am, Tuesday, 26'th Oct 2021
The stock price of Ocugen Inc (NASDAQ: OCGN) increased by over 24% pre-market today. This is why it happened.
Shares of Ocugen Inc. (NASDAQ: OCGN) surged almost 12.3% in Monday's regular trading session and another 38.5% in the after-hours session in anticipation of a key event taking place Tuesday. What Hap
Investors are in a speculative frenzy around COVAXIN ahead of a WHO meeting tomorrow. OCGN stock is rallying as a result.
These stocks could soon take flight.

OCGN Stock: Why The Price Increased Today

06:44am, Wednesday, 20'th Oct 2021
The stock price of Ocugen, Inc. (NASDAQ: OCGN) increased by over 5% pre-market today. This is why it happened.

3 Biotech Stocks That Are Ridiculously Overpriced

06:02am, Wednesday, 20'th Oct 2021
They've risen too far, too quickly.
OCGN stock has suffered as a Covid-19 vaccine latecomer, but news that Covaxin won emergency approval in India sent shares soaring. The post Ocugen Surged on Its Covid Vaccine Emergency Approval in In

Is Now a Good Time to Buy Ocugen?

11:15am, Tuesday, 19'th Oct 2021
There is a lot of uncertainty surrounding this biotech's prospects.
MALVERN, Pa., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness disea
Highly volatile, with a tendency to make unwarranted moves higher, it's best to not go long (or short) OCGN stock. The post This Ocugen Stock Rally Makes Little Sense, But Watch Out Going Short appear
These COVID-19 vaccine developers are all moving in response to strong late-stage results for Valneva's VLA2001.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE